Prognostic Stage IV Breast Cancer AJCC v8 Active Not Recruiting Phase 1 Trials for Talimogene laherparepvec (DB13896)

IndicationStatusPhase
DBCOND0109667 (Prognostic Stage IV Breast Cancer AJCC v8)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03554044T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast CancerTreatment